Exact Mass: 306.0407
Exact Mass Matches: 306.0407
Found 61 metabolites which its exact mass value is equals to given mass value 306.0407
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate
2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.
Vadadustat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate
4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid
4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate
Methyl brevifolincarboxylate
Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.
6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C
7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one
6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]
Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate
4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile
2-[[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile
5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE
3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate
3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione
6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine
5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid
4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate
N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide
2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid
(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid
4-(5-O-phospho-beta-D-ribofuranosyl)phenol
A ribose monophosphate that is D-ribofuranose 5-phosphate in which the anomeric OH group is replaced by a 4-hydroxy phenyl group (the beta-D-anomer).
1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one
A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.